These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6985269)

  • 1. Inhibition of in vitro natural killer activity by the third component of complement: role for the C3a fragment.
    Charriaut C; Senik A; Kolb JP; Barel M; Frade R
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6003-7. PubMed ID: 6985269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of natural-killer cell cytotoxicity and enhancement of complement factors in the spontaneously aborted mouse placenta.
    Kusakabe K; Naka M; Ito Y; Eid N; Otsuki Y
    Fertil Steril; 2008 Oct; 90(4 Suppl):1451-9. PubMed ID: 18068164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of complement in the immune response.
    Feldbush TL; Hobbs MV; Severson CD; Ballas ZK; Weiler JM
    Fed Proc; 1984 Jul; 43(10):2548-52. PubMed ID: 6610570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of secondary in vitro antibody responses by the third component of complement.
    Hobbs MV; Feldbush TL; Needleman BW; Weiler JM
    J Immunol; 1982 Mar; 128(3):1470-5. PubMed ID: 6460062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-methylcholanthrene: transient inhibition of the lytic step of mouse natural killer cells.
    Kalland T; Forsberg JG
    J Natl Cancer Inst; 1983 Aug; 71(2):385-90. PubMed ID: 6576196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement-dependent cellular cytotoxicity due to alternative pathway C3 activation by the target cell membrane.
    Yefenof E; Yron I; Klein E
    Cell Immunol; 1984 Sep; 87(2):698-702. PubMed ID: 6467388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement inhibits immune responses: C3 preparations inhibit the generation of human cytotoxic T lymphocytes.
    Ballas ZK; Feldbush TL; Needleman BW; Weiler JM
    Eur J Immunol; 1983 Apr; 13(4):279-84. PubMed ID: 6189721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The secreted Candida albicans protein Pra1 disrupts host defense by broadly targeting and blocking complement C3 and C3 activation fragments.
    Luo S; Dasari P; Reiher N; Hartmann A; Jacksch S; Wende E; Barz D; Niemiec MJ; Jacobsen I; Beyersdorf N; Hünig T; Klos A; Skerka C; Zipfel PF
    Mol Immunol; 2018 Jan; 93():266-277. PubMed ID: 28860090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution conformation of carboxy-terminal fragments of the third component of human complement C3: proton nuclear magnetic resonance study of C3a, des-Arg-C3a, and C3a Arg69.
    Muto Y; Fukumoto Y; Arata Y
    J Biochem; 1987 Sep; 102(3):635-41. PubMed ID: 3501427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inability of the C3a anaphylatoxin to promote cellular lysis.
    Goodman MG; Weigle WO; Hugli TE
    Nature; 1980 Jan; 283(5742):78-80. PubMed ID: 7350527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA; Pedersen KF; Welsh RM
    J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton nuclear magnetic resonance study of the third component of complement: solution conformation of the carboxyl-terminal segment of C3a fragment.
    Muto Y; Fukumoto Y; Arata Y
    Biochemistry; 1985 Nov; 24(23):6659-65. PubMed ID: 3878728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylatoxin-mediated regulation of the immune response. I. C3a-mediated suppression of human and murine humoral immune responses.
    Morgan EL; Weigle WO; Hugli TE
    J Exp Med; 1982 May; 155(5):1412-26. PubMed ID: 6978374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient complement inhibition promotes a tumor-specific immune response through the implication of natural killer cells.
    Janelle V; Langlois MP; Tarrab E; Lapierre P; Poliquin L; Lamarre A
    Cancer Immunol Res; 2014 Mar; 2(3):200-6. PubMed ID: 24778316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis and quantification of the complement C3 derived anaphylatoxin C3a with a monoclonal antibody.
    Burger R; Bader A; Kirschfink M; Rother U; Schrod L; Wörner I; Zilow G
    Clin Exp Immunol; 1987 Jun; 68(3):703-11. PubMed ID: 3498585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.